Article Text

Download PDFPDF

60 Association of systemic lupus erythematosus (SLE) genetic susceptibility loci with lupus nephritis in childhood-onset and adult-onset with SLE
  1. Declan Webber1,
  2. Jingjing Cao1,
  3. Daniela Dominguez1,
  4. Dafna D Gladman2,
  5. Deborah Levy3,
  6. Lawrence Ng1,
  7. Andrew Paterson4,
  8. Zahi Touma2,
  9. Murray B Urowitz2,
  10. Joan Wither5,
  11. Earl D Silverman1 and
  12. Linda T Hiraki1
  1. 1The Hospital for Sick Children
  2. 2Krembil Research Institute, University of Toronto
  3. 3Hospital for Sick Children and University of Toronto
  4. 4Sickkids Hosp
  5. 5University of Toronto


Background Lupus nephritis (LN) is one of the most common and severe manifestations of systemic lupus erythematosus (SLE). We tested the association of SLE-risk loci with LN risk in childhood- (cSLE) and adult-onset SLE (aSLE).

Methods Two Toronto-based tertiary care SLE cohorts included cSLE (diagnosed <18 y) and aSLE patients (diagnosed 18y). Patients met ACR and/or SLICC SLE criteria and were genotyped on the Illumina MEGA or Omni1 arrays. Ungenotyped SNPs were imputed (1000 Genomes Project). HLA alleles were imputed in the Europeans only (SNP2HLA). Ancestry was inferred using principal components. We identified those with and without biopsy confirmed LN. HLA and non-HLA additive SLE risk-weighted genetic risk scores (GRSs) were tested for association with LN risk in logistic models, stratified by cSLE/aSLE and ancestry. Stratified effect estimates were meta-analyzed.

Results Of 1237 participants, 572 had cSLE (41% with LN) and 665 had aSLE (30% with LN). Increasing non-HLA GRS was significantly associated with increased LN risk (OR=1.26; 95% CI: 1.09, 1.46, p=0.0006) as was increasing HLA GRS in Europeans (OR=1.55; 95% CI: 1.07, 2.25; p=0.03). There was a trend for stronger associations between both GRSs and LN risk in Europeans with cSLE compared with aSLE.

Conclusions We observed an association between known SLE-risk loci and LN risk in children and adults with SLE, with the strongest effect observed among Europeans with cSLE. Future directions will include incorporating SLE-risk SNPs specific to non-European ancestral groups and validating findings in an independent cohort.

Funding Source(s): Dr. Hiraki: Canadian Institute of Health Research (CIHR) Project Scheme grant

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.